4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-25-002705
Chief Medical Officer sold 11,624 shares at $0.45 ($5,284)
- Chief Medical Officer acquired 25,831 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Arbet-Engels Christophe Chief Medical Officer | 2025-01-23 | Grant or award | +25,831 | 25,831 | D | ||
| Arbet-Engels Christophe Chief Medical Officer | 2025-01-24 | Sale | −11,624 | $0.45 | $5,284 | 14,207 | D |
| Open-market sales · 11,624 sh · avg $0.45 · $5,284 | |||||||
Loading xslF345X05/wk-form4_1738019705.xml…